Here are five things to know about the network:
- Four NIAID-funded clinical trials networks joined forces to form the The COVPN: the Seattle-based HIV Vaccine Trials Network, the Durham, N.C.-based HIV Prevention Trials Network, the Atlanta-based Infectious Diseases Clinical Research Consortium and the Los Angeles-based AIDS Clinical Trials Group. The HIV Vaccine Trials Network will act as the network’s operational center.
- Larry Corey, MD, of the Seattle-based Fred Hutchinson Cancer Research Center and Kathleen Neuzil, MD, of Baltimore-based University of Maryland School of Medicine will lead the network’s vaccine testing.
- Myron S. Cohen, MD, of the University of North Carolina, Chapel Hill and David Stephens, MD, of Atlanta-based Emory University will lead the network’s monoclonal antibody clinical testing.
- The COVPN’s first phase 3 clinical trial, expected to launch this summer, will test Moderna’s mRNA-1273 vaccine.
- The network plans to conduct clinical testing at more than 100 sites domestically and internationally.
More articles on pharmacy:
CVS develops app to read prescription labels for visually impaired patients
Sandoz to supply Civica Rx with 6 injectable drugs
The specialty pharmacy divide: How health systems and payers can find common ground
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
